DJ

Dana Johnson

CEO

Saol Therapeutics

Parker, Colorado


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Saol Therapeutics
Industry
pharmaceuticals
Employees
39.0
Seniority
C suite
Annual Revenue
25000000.0
Total Funding
16746017.0
Latest Funding
Venture (Round not Specified)

Technologies

Outlook Microsoft Office 365 DigitalOcean Nginx Google Analytics reCAPTCHA Gravity Forms WordPress.org Google Tag Manager Google Font API Mobile Friendly Vimeo Remote AI

Keywords

rare disease cns clinical development pain osteoarthritis spasticity orphan disease mitochondrial disorders biotechnology pharmaceuticals pharmaceutical manufacturing clinical-stage pharmaceutical company cns disorders pain management orphan diseases sl-1002 sl-1009 late-stage clinical development neurolytic agent novel treatments fda approval clinical trials patient-centric innovative therapies opioid alternatives kinetic analysis pharmaceutical innovation therapeutic areas disease models biopharmaceutical partnerships research collaborations regulatory compliance market access investor partnerships drug development preclinical studies patients care drug delivery systems disease burden market research healthcare outcomes clinical research pharmacovigilance medical affairs strategic planning ongoing trials surgical management therapeutic alternatives rare diseases metabolic disorders health technology clinical pipelines medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans